Savant Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.12M Buy
85,881
+673
+0.8% +$46K 0.03% 242
2025
Q4
$5.04M Buy
85,208
+240
+0.3% +$13K 0.03% 250
2025
Q3
$4.69M Buy
84,968
+34
+0% +$1.77K 0.03% 244
2025
Q2
$3.66M Sell
84,934
-63
-0.1% -$2.43K 0.03% 255
2025
Q1
$3.37M Buy
84,997
+4
+0% +$177 0.03% 238
2024
Q4
$3.46M Sell
84,993
-1,273
-1% -$53K 0.03% 298
2024
Q3
$3.36M Buy
86,266
+1,783
+2% +$71K 0.03% 298
2024
Q2
$3.69M Sell
84,483
-120
-0.1% -$5.8K 0.04% 240
2024
Q1
$4.04M Buy
84,603
+276
+0.3% +$12.4K 0.05% 213
2023
Q4
$3.98M Buy
84,327
+342
+0.4% +$14.2K 0.05% 199
2023
Q3
$4M Sell
83,985
-45
-0.1% -$2.46K 0.06% 184
2023
Q2
$4.89M Buy
84,030
+119
+0.1% +$7.14K 0.08% 162
2023
Q1
$6M Buy
+83,911
New +$6.66M 0.11% 125

Other funds holding NGVT

Savant Capital's NGVT Position: Q1 2026 in Review

Savant Capital increased its Ingevity (NGVT) stake by 0.79% in Q1 2026, buying an estimated $46K and bringing the position to 85,881 shares worth $6.12M. The position accounts for 0.03% of the portfolio, ranked #242.

Savant Capital first reported a position in NGVT in Q1 2023 and has held it in 13 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Savant Capital held 85,881 shares of Ingevity worth $6.12M as of Q1 2026.
  • Savant Capital bought 673 Ingevity shares in Q1 2026, an estimated $46K.
  • Ingevity made up 0.03% of Savant Capital's portfolio in Q1 2026, its #242 holding.
  • Savant Capital first reported a position in Ingevity in Q1 2023 and has held it in 13 quarters since.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.